A systematic review of changes in melanocytic naevi during immune checkpoint inhibition and targeted therapy

• T.V.M. Bruijn,
• S.T. Dinh,
• Y.S. Elshot,
• S. van der Mierden,
• P.H. Soyer,
• C.M. Olsen,
• B. Betz-Stablein,
• M.W. Bekkenk,
• T. Rustemeyer,
• E.I. Plasmeijer

Affiliations

T.V.M. Bruijn

The Netherlands Cancer Institute – Antoni van Leeuwenhoek, Department of Dermatology, Amsterdam, The Netherlands; Amsterdam UMC, Department of Dermatology, Amsterdam, The Netherlands

S.T. Dinh

The Netherlands Cancer Institute – Antoni van Leeuwenhoek, Department of Dermatology, Amsterdam, The Netherlands

Y.S. Elshot

The Netherlands Cancer Institute – Antoni van Leeuwenhoek, Department of Dermatology, Amsterdam, The Netherlands; Amsterdam UMC, Department of Dermatology, Amsterdam, The Netherlands

S. van der Mierden

The Netherlands Cancer Institute – Antoni van Leeuwenhoek, Scientific Information Service – NKI Library, Amsterdam, The Netherlands

P.H. Soyer

Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia

C.M. Olsen

Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia; QIMR Berghofer Medical Research Institute, Department of Population Health, Brisbane, Australia

B. Betz-Stablein

Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia

M.W. Bekkenk

Amsterdam UMC, Department of Dermatology, Amsterdam, The Netherlands

T. Rustemeyer

Amsterdam UMC, Department of Dermatology, Amsterdam, The Netherlands

E.I. Plasmeijer

The Netherlands Cancer Institute – Antoni van Leeuwenhoek, Department of Dermatology, Amsterdam, The Netherlands; Leiden University Medical Center, Department of Dermatology, Leiden, The Netherlands